The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 6th 2025
A rehabilitation method commonly used in patients who experience a traumatic brain injury was found to improve symptoms of long COVID, including brain fog and measures of daily living.
FDA's Warning About Teething Products Gets Quick Response
October 13th 2016In response to the FDA's warning about the safety of homeopathic teething tablets and gels, Hyland's has voluntarily decided to discontinue distributing its teething products in the United States, while CVS has immediately pulled all of its own brand of homeopathic teething products from its shelves, as well as Hyland's and Baby Orajel Naturals.
Read More
FDA Approves FluBlok Quadrivalent Flu Vaccine
October 13th 2016The FDA has approved its quadrivalent formulation of Protein Sciences' Flublok influenza vaccine for protection against 4 strains of influenza-3 of the same strains found in its trivalent version, along with an additional B strain. It is the first high-antigen-content quadrivalent flu vaccine approved by the FDA.
Read More
A comprehensive medication management program designed to optimize therapy and boost adherence to hepatitis C virus medications saved a state Medicaid program nearly $3.8 million in avoided costs, according to a new study in the Journal of Managed Care & Specialty Pharmacy (JMCP).
Read More
Bridging to Warfarin with Heparin in Atrial Fibrillation Isn't Necessary, May Be Harmful
October 10th 2016Little information exists regarding the benefit of bridging warfarin among patients with atrial fibrillation. The best available evidence suggests that this common practice may increase the risk of bleeding without providing any efficacy benefit.
Read More
FDA Approves New Continuous Glucose Monitoring System for Diabetes
October 7th 2016The FDA has approved a new continuous glucose monitoring (CGM) system designed to provide health care professionals with clear, visual snapshots of glucose levels, trends, and patterns in patients with diabetes at a lower cost than other CGM devices on the market.
Read More